إعلان شركة دله للخدمات الصحية عن تشكيل لجنة المراجعة

Dallah Healthcare Co. Announces Appointment Audit Committee Member 4004 DALLAH HEALTH 1.41 % 1447/04/30     22/10/2025 08:18:14 Introduction The Board of Directors of Dallah Healthcare Company announces the formation of the Audit Committee for the new term of the Board, which will commence on 21 October 2025G and will continue for four (4) calendar years, ending on 20 October 2029G. Appointed Member Name Mr. Fahad Bin Abdullah Al-kassim(from outside the Board) Membership Start Date 2025-10-21 Corresponding to 1447-04-29 Brief Resume of the Appointed Member Mr. Fahad bin Abdullah Al-kassim holds a bachelor’s degree in Accounting from King Saud University and a certificate in Advanced Management and Leadership from the University of Oxford. He is a Certified Public Accountant and a Certified Real Estate Appraiser. He has extensive experience in financial, administrative, and real estate fields and serves as a member and chairman of several boards of directors and committees in listed and closed companies across various sectors The date of the approval by other official authorities Not applicable Appointed Member Name Mr. Ahmed Abdullah Al-Alsheikh(Board Member / Independent) Membership Start Date 2025-10-21 Corresponding to 1447-04-29 Brief Resume of the Appointed Member Mr. Ahmed bin Abdullah Al-Sheikh holds a bachelor’s degree in Accounting from King Saud University and a Leadership Program certificate from INSEAD. He has extensive experience in governance, oversight, and financial supervision through his work at the Saudi Central Bank and the Capital Market Authority. He currently serves as a member and chairman of several audit and risk committees in government entities and investment companies across both the public and private sectors. The date of the approval by other official authorities Not applicable Appointed Member Name Not applicable. Mr. Khaled Abdulaziz Al-Rayes (Board Member / Independent) Membership Start Date 2025-10-21 Corresponding to 1447-04-29 Brief Resume of the Appointed Member Mr. Khalid bin Abdulaziz Al-Rayes is the Chief Executive Officer of Alistithmar Capital. He has nearly 22 years of professional experience in investment banking, asset management, direct investments, and private equity. Before joining Alistithmar Capital, he served as the Investment Director at Aseer Company, a diversified investment firm managing a portfolio that includes direct investments, private equity, listed equities, and real estate investments. Prior to that, he was the Head of Investment Banking at Al Rajhi Capital and also worked at Alistithmar Capital as an Investment Banking Director. Al-Rayes has successfully completed numerous rights issues, private placements, mergers and acquisitions, and corporate restructuring transactions across various sectors. He has also served on the boards of directors and committees of several limited liability and closed joint-stock companies across multiple industries, including food and beverage manufacturing, packaging, real estate investment, and private equity. Khalid Al-Rayes holds dual master’s degrees — an MBA and a Master of Science in Finance — from the University of Denver, Colorado. He is also a Chartered Financial Analyst (CFA) The date of the approval by other official authorities Not applicable Appointed Member Name Mr. khalid bin Mohmmed Al-Solai (from outside the Board) Membership Start Date 2025-10-21 Corresponding to 1447-04-29 Brief Resume of the Appointed Member Mr. Khalid bin Mohammed Al-Sulai holds a bachelor’s degree in Accounting from King Saud University and a diploma in Economics and Management from the Economic Institute in the United States. He has obtained several professional fellowships in the fields of accounting and auditing. He has practical experience serving on the boards of companies and organizations, as well as chairing and participating in audit committees. The date of the approval by other official authorities Not applicable Date of Board Meeting in which Appointed New Member(s) were Appointed 2025-10-21 Corresponding to 1447-04-29 Additional Information The Board of Directors’ resolution to form the Audit Committee shall be effective as of 21/10/2025G, and the committee’s term shall continue for four (4) years, ending on 20/10/2029G. The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. Share Previous Announcements Announcement of Dallah Healthcare Company regarding the Board of Directors’ recommendation to increase the Company’s capital through Issuance of Bonus Shares Announcement of Dallah Healthcare Company regarding the Board of Directors’ recommendation to increase the Company’s capital through Issuance of Bonus Shares 4004 DALLAH HEALTH 1.41 % 1447/09/15     04/03/2026 16:05:44 Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the fourth quarter of 2025. Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the fourth quarter of 2025. 4004 DALLAH HEALTH 1.41 % 1447/09/15     04/03/2026 15:53:55 Dallah Healthcare Co. announces its Annual Financial results for the period ending on 2025-12-31 Dallah Healthcare Co. announces its Annual Financial results for the period ending on 2025-12-31 4004 DALLAH HEALTH 1.41 % 1447/09/15     04/03/2026 15:52:31 View all announcements Company Performance DALLAH HEALTH Add To Watchlist In your Watchlist Add To Watchlist Zoom 1D 1M 3M 1Y 3Y 5Y Inception Created with Highcharts 10.0.0 Highcharts Stock Responsive Chart Click small/large buttons or change window size to test responsiveness 10:05 10:10 10:15 10:20 10:10 10:20 133 134 135 136 137 138 Zoom Zoom ▾ 1M 3M 1Y 3Y 5Y Inception Apr 12, 2026 → Apr 12, 2026 Key Parameters Last Price 136.6 Net Change 1.9 (+1.41%) Value Traded (Sar) 1,638,098.9 Volume Traded 12,120 See The Company Profile Upcoming Calendar Dates 4004 DALLAH HEALTH | 2026-03-04 4004 DALLAH HEALTH | 2025-11-03 4004 DALLAH HEALTH | 2025-10-21 LoginPortletPopupv2 /wps/contenthandler/!ut/p/digest!d-TFOArravMA-banFwcqow/pm/oid:--portletwindowid--@oid:Z6_5A602H80O0HTC060SG6UT81DI3 /wps/contenthandler/!ut/p/digest!d-TFOArravMA-banFwcqow/um/secure/currentuser/profile?expandRefs=true Log in to access your watchlist Error Here Error Here Log In Don't Have Account? Register Here Forgot Password? Forgot Password Error Submit Welcome Please select a mode of authentication SMS Verification (OTP) Sent Email Verification (OTP) Sent to Error Send OTP Enter OTP OTP is not valid Confirm Resend AddtoWatchlistv2 NO PORTLET SESSION YET